New Studies Show Promise for Maintaining Weight Loss with Orforglipron and Bacterial Preparations
Two recent studies published in Nature Medicine explore effective remedies to prevent the yo-yo effect after initial weight loss. The first study focused on orforglipron, an oral tablet acting similarly to weight-loss injections. Participants who switched from injections to daily orforglipron tablets retained 75 to 80 percent of their weight loss after one year, significantly outperforming the placebo group, which retained only 38 to 49 percent. While side effects were primarily gastrointestinal, the tablets offer advantages in ease of use, storage, and potential cost compared to injectables. The second study investigated a bacterial preparation containing Akkermansia muciniphila. This probiotic approach showed moderate success in maintaining weight over a 24-week period. However, experts caution against immediate widespread recommendations due to the small sample size and short observation duration of this trial. These findings highlight potential pharmaceutical and biological strategies for long-term weight management, addressing a common challenge where weight is regained after stopping traditional diet programs or injections. Further long-term research is needed to confirm the sustained efficacy of these treatments.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection